(19)
(11) EP 4 584 256 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23765257.3

(22) Date of filing: 05.09.2023
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
A61P 35/00(2006.01)
 A61K 31/4709(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 401/14
(86) International application number:
PCT/EP2023/074310
(87) International publication number:
WO 2024/052333 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 06.09.2022 EP 22194233
17.10.2022 EP 22201953
12.03.2023 EP 23161360

(71) Applicant: Philochem AG
8112 Otelfingen (CH)

(72) Inventors:
  • BOCCI, Matilde
    8112 Otelfingen (CH)
  • CAZZAMALLI, Samuele
    8112 Otelfingen (CH)
  • GALBIATI, Andrea
    8112 Otelfingen (CH)
  • NERI, Dario
    8112 Otelfingen (CH)
  • ZANA, Aureliano
    8112 Otelfingen (CH)
  • GILARDONI, Ettore
    8112 Otelfingen (CH)
  • PRINCIPI, Lucrezia
    8112 Otelfingen (CH)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) MULTIVALENT FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS